NM_031475.3:c.2026A>G
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_031475.3(ESPN):c.2026A>G(p.Thr676Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T676R) has been classified as Likely benign.
Frequency
Consequence
NM_031475.3 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
- autosomal recessive nonsyndromic hearing loss 36Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Usher syndrome type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Usher syndrome, type 1MInheritance: AR, Unknown Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248544 AF XY: 0.00000741 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000205 AC: 3AN: 1460610Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726572 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Thr676Ala variant in ESPN has not been previously reported in individuals wi th hearing loss. Frequency data from large populations studies is insufficient. Computational analyses (biochemical amino acid properties, conservation, AlignGV GD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, additional data is needed to determine the clinical significance of this variant. -
Inborn genetic diseases Uncertain:1
The c.2026A>G (p.T676A) alteration is located in exon 9 (coding exon 9) of the ESPN gene. This alteration results from a A to G substitution at nucleotide position 2026, causing the threonine (T) at amino acid position 676 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at